| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.27 | 1e-06 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.32 | 3e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.33 | 3e-06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.22 | 7e-06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.25 | 1e-05 |